For example, a large-scale GWAS study found that LOXL1 variants can increase the deposition of elastin and fibrillin-1 that stabilizes the ECM, thereby protecting against exfoliation syndrome (40). The gene discussed is FBN1; the disease is exfoliation syndrome.